This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Delayed milestone in childhood
R18_DELAY_MILES_CHILDH
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
712 |
4. Check minimum number of eventsNone |
712 |
5. Include endpointsNone |
712 |
6. Filter based on genotype QC (FinnGen only) |
619 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- R62
Similar endpoints
↥List of similar endpoints to
Delayed milestone in childhood
based on the number of shared cases.
Similar with more cases:
- Lack of expected normal physiological development
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 619 | 266 | 353 |
| Unadjusted period prevalence (%) | 0.13 | 0.09 | 0.16 |
| Median age at first event (years) | 2.87 | 2.63 | 3.06 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 678
- Matched controls
- 6081
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R62.0
ICD-10 Finland
Delayed milestone
+∞
307.7
678
48
F83
ICD-10 Finland
Mixed specific developmental disorders
14.3
185.5
206
180
F82
ICD-10 Finland
Specific developmental disorder of motor function
11.3
113.7
139
136
XA800
NOMESCO Finland
Neuropsychological investigation
7.6
111.9
202
322
RL140, ,
NOMESCO Finland
20.3
99.1
84
42
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
14.0
93.0
96
71
Z3226
NOMESCO Finland
Physiotherapist
4.8
87.7
324
970
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.4
86.8
238
557
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.4
86.5
151
228
Z2445
NOMESCO Finland
Psychologist
5.4
84.8
223
502
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.3
80.3
165
294
R4110
NOMESCO Finland
Physiotherapy
4.4
77.4
329
1076
F80.1
ICD-10 Finland
Expressive language disorder
8.5
76.0
112
138
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
15.1
75.9
74
49
R4120
NOMESCO Finland
Occupational therapy
6.5
75.8
149
253
P85
ICPC
Mental retardation
11.6
72.6
83
72
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.7
70.7
132
212
RL130, ,
NOMESCO Finland
14.5
70.4
70
48
Z2446
NOMESCO Finland
Social worker
4.3
68.5
256
750
RT150, ,
NOMESCO Finland
12.1
66.7
74
61
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.1
65.7
267
828
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
8.8
65.6
92
106
Z31.5
ICD-10 Finland
Genetic counselling
4.9
55.7
151
339
R4130
NOMESCO Finland
Speech therapy
6.4
54.4
103
166
RT490, ,
NOMESCO Finland
18.6
49.7
43
22
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
49.6
290
1108
F80.2
ICD-10 Finland
Receptive language disorder
7.2
49.2
81
112
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.9
44.0
112
236
Z2221
NOMESCO Finland
Medical doctor
3.1
41.1
263
1039
R1260
NOMESCO Finland
Evaluation of communicative skills
9.0
41.0
55
59
602
Kela drug reimbursment
Children's severe malnutrition
5.3
40.7
93
178
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
39.8
262
1048
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
39.5
196
664
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
37.5
150
441
Z50.5
ICD-10 Finland
Speech therapy
4.2
36.5
113
277
N03AG01
ATC
valproic acid; systemic, rectal
4.8
36.3
93
196
Z3231
NOMESCO Finland
Registered nurse
2.7
35.1
350
1716
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.3
34.2
100
234
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
7.3
34.1
54
71
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
33.8
223
880
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.4
33.7
95
216
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
33.7
321
1531
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
32.8
169
579
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.3
32.6
72
133
N05BA09
ATC
clobazam; oral
6.7
32.1
55
79
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.4
31.8
135
410
N03AX14
ATC
levetiracetam; systemic
5.4
31.6
69
126
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.9
31.3
61
100
RS222, ,
NOMESCO Finland
7.0
30.6
50
68
N05CD08
ATC
midazolam; nasal, systemic
4.9
30.6
74
148
H50.31
ICD-10 Finland
Intermittent exotropia
5.7
29.9
60
101
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
29.5
199
787
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
28.6
133
426
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
10.7
28.2
33
29
183
Kela drug reimbursment
Lamotrigin and topiramate
7.9
28.0
41
49
RT160, ,
NOMESCO Finland
7.4
27.7
43
55
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.0
26.9
86
214
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
26.7
127
411
A28
ICPC
Limited function/disability NOS
3.6
25.8
95
261
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.2
25.3
121
392
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.0
24.8
128
433
FM2CE, ,
NOMESCO Finland
3.2
24.5
115
368
ZXE00
NOMESCO Finland
One hour or less
2.3
24.4
327
1752
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
23.9
261
1279
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
23.7
159
619
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
23.5
176
724
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.1
23.2
33
38
DFF20
NOMESCO Finland
Audiometry for children
4.5
23.0
61
131
RD210, ,
NOMESCO Finland
3.4
22.9
92
267
TJD20
NOMESCO Finland
Change of gastrostomy tube
7.3
22.4
35
45
H50.30
ICD-10 Finland
Intermittent esotropy
5.5
22.4
46
79
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
7.5
21.8
33
41
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.2
21.6
63
146
R5599
NOMESCO Finland
Other rehabilitation service
4.6
21.4
55
115
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
21.4
109
365
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
21.3
204
935
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.0
21.2
107
356
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
6.8
21.2
35
48
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
20.7
114
398
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
5.7
20.7
41
68
H01AC01
ATC
somatropin; parenteral
3.9
20.6
66
164
RT190, ,
NOMESCO Finland
18.8
20.6
32
16
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
6.8
20.4
34
47
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.5
19.7
76
214
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.3
19.7
54
119
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
20.8
19.3
29
13
N03AX09
ATC
lamotrigine; oral
3.9
19.3
62
154
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
5.7
19.2
38
63
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
19.1
90
287
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.6
19.1
70
191
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
18.8
254
1331
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
18.6
94
312
RS220, ,
NOMESCO Finland
4.8
18.2
43
84
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.1
18.0
40
74
R1250
NOMESCO Finland
Evaluation of functional capability
5.8
17.6
34
55
WX882
NOMESCO Finland
High dependency care
2.5
17.5
127
509
WX730
NOMESCO Finland
Conventional respirator
6.7
17.4
29
40
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.7
17.4
109
406
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
15.0
17.3
29
18
N05AX08
ATC
risperidone; systemic
3.3
17.2
71
209
H50.0
ICD-10 Finland
Convergent concomitant strabismus
4.8
16.9
40
78
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
15.4
16.9
28
17
DFF00
NOMESCO Finland
Pure tone audiometry
3.3
16.8
67
193
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
5.1
16.7
37
68
H52.2
ICD-10 Finland
Astigmatism
3.4
16.7
65
184
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
4.3
16.7
46
102
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
16.6
103
381
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
16.6
75
233
H50.1
ICD-10 Finland
Divergent concomitant strabismus
7.5
16.5
25
31
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.8
16.1
38
74
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.5
15.8
32
54
XX4AW, ,
NOMESCO Finland
3.8
15.8
51
127
ZX199
NOMESCO Finland
Other rote
5.7
15.8
31
51
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
21.3
15.6
23
10
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
21.3
15.6
23
10
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.5
15.5
58
160
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
15.5
104
400
F84.0
ICD-10 Finland
Childhood autism
7.2
15.3
24
31
WX722
NOMESCO Finland
PEEP
3.7
15.1
51
131
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
30.7
15.0
20
6
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
14.9
70
222
ZXD05
NOMESCO Finland
Urgent procedure
2.1
14.7
169
819
ZX114
NOMESCO Finland
Intramuscular
4.6
14.5
36
73
XKD00
NOMESCO Finland
Uroflowmetry
3.5
14.5
53
144
ZY010
NOMESCO Finland
Hospital outpatient
2.4
14.5
115
478
NF1DA
NOMESCO Finland
X-ray of hips
6.4
14.4
25
36
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
14.2
75
254
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
14.1
62
189
M41.4
ICD-10 Finland
Neuromuscular scoliosis
12.9
14.1
25
18
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
14.1
141
646
C03CA01
ATC
furosemide; systemic
3.6
14.1
50
133
E34.35
ICD-10 Finland
Abnormal growth retardation
3.2
13.9
59
176
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
13.8
119
512
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
6.6
13.7
23
32
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
13.7
161
786
ZX108
NOMESCO Finland
Inhalation
5.4
13.6
28
48
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
13.5
98
390
P94.2
ICD-10 Finland
Congenital hypotonia
39.0
13.4
17
*
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.6
13.0
46
122
R5140
NOMESCO Finland
Monitoring the use of the aid
5.0
12.9
29
54
RS140, ,
NOMESCO Finland
10.5
12.9
25
22
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
12.8
215
1186
TJF80
NOMESCO Finland
Ostomy education
6.1
12.6
23
35
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
5.0
12.5
28
52
RT130, ,
NOMESCO Finland
13.8
12.3
21
14
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.6
12.3
30
60
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.1
12.3
53
160
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
15.4
12.2
20
12
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
12.1
166
853
WX402
NOMESCO Finland
General anaesthesia
1.9
12.0
214
1199
301
Kela drug reimbursment
Growth hormone
4.4
12.0
31
65
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
10.6
12.0
23
20
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
5.7
11.9
23
37
N05BA01
ATC
diazepam; systemic, rectal
3.0
11.8
56
179
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
4.7
11.7
28
55
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
11.7
46
131
B01AA03
ATC
warfarin; systemic
4.6
11.7
29
59
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
11.6
38
96
RS314, ,
NOMESCO Finland
13.2
11.5
20
14
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.3
11.5
45
128
R62.9
ICD-10 Finland
Lack of expected normal physiological development, unspecified
14.6
11.4
19
12
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.8
11.3
60
204
RS211, ,
NOMESCO Finland
4.4
11.2
29
61
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.0
11.2
51
159
H52.0
ICD-10 Finland
Hypermetropia
2.8
11.1
61
211
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.5
11.0
40
108
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.1
10.9
48
147
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.6
10.7
26
52
Z93.1
ICD-10 Finland
Gastrostomy status
13.8
10.6
18
12
F88
ICD-10 Finland
Other disorders of psychological development
3.8
10.6
33
80
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.0
10.6
48
149
N03AF03
ATC
rufinamide; oral
22.9
10.6
15
6
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
10.5
41
116
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
9.7
10.5
21
20
N03AF02
ATC
oxcarbazepine; oral
3.0
10.5
48
150
181
Kela drug reimbursment
Retigabine and vigabatrin
8.8
10.5
22
23
G40.89
ICD-10 Finland
Other epilepsy
8.8
10.5
22
23
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
10.5
139
703
RT274, ,
NOMESCO Finland
11.7
10.4
19
15
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.4
10.4
75
297
205
Kela drug reimbursment
Chronic hypertension
3.6
10.4
35
90
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.0
10.4
30
69
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.8
10.4
24
46
UDC00
NOMESCO Finland
Ear microscopy
2.3
10.3
82
339
WX892
NOMESCO Finland
Monitored bed care
2.4
10.3
76
304
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
4.9
10.2
23
43
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
10.2
285
1807
Q21.10
ICD-10 Finland
Persistent ostium secundum
3.1
10.2
45
138
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
10.1
73
289
P07.3
ICD-10 Finland
Other preterm infants
2.7
10.1
57
200
SPAT1229
SPAT
Assessment of need for aid
4.8
9.9
23
44
ZXA00
NOMESCO Finland
Right side
2.2
9.9
97
438
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.6
9.9
24
48
ZXA10
NOMESCO Finland
Bilateral
2.0
9.8
132
669
C03DA01
ATC
spironolactone; oral
3.1
9.8
43
131
N03AX11
ATC
topiramate; oral
3.9
9.8
30
72
F84.8
ICD-10 Finland
Other pervasive developmental disorders
4.0
9.8
28
64
F79
ICD-10 Finland
Unspecified mental retardation
14.7
9.7
16
10
Q93.8
ICD-10 Finland
Other deletions from the autosomes
14.7
9.7
16
10
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.3
9.7
38
108
K03.66
ICD-10 Finland
Tooth plaque
1.9
9.7
162
882
UKC02
NOMESCO Finland
Cystoscopy
3.5
9.7
34
90
XG413
NOMESCO Finland
Spirometry with oscillometry
3.2
9.6
40
118
P07.2
ICD-10 Finland
Extreme immaturity
9.7
9.6
19
18
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.4
9.6
69
273
N03AG04
ATC
vigabatrin; oral
7.5
9.6
22
27
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.7
9.5
54
190
ZX120
NOMESCO Finland
Intravenous
2.4
9.5
72
292
ZXD20
NOMESCO Finland
Day surgery
2.4
9.5
72
292
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.5
9.5
33
87
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
3.8
9.4
30
74
L28
ICPC
Limited function/disability (L)
2.5
9.4
62
235
J96.1
ICD-10 Finland
Chronic respiratory failure
13.3
9.4
16
11
199
Kela drug reimbursment
Rufinamide
23.7
9.3
13
5
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.1
9.2
99
463
Z50.1
ICD-10 Finland
Other physical therapy
4.2
9.2
25
55
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.8
9.1
47
157
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.7
9.1
51
178
H47.2
ICD-10 Finland
Optic atrophy
9.7
9.1
18
17
RS142, ,
NOMESCO Finland
12.2
9.1
16
12
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.4
9.0
23
48
RF120, ,
NOMESCO Finland
7.2
8.9
21
27
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
3.3
8.9
35
100
Q75.3
ICD-10 Finland
Macrocephaly
16.0
8.9
14
8
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.8
8.7
20
38
RK220, ,
NOMESCO Finland
5.0
8.6
19
35
A06AD11
ATC
lactulose; oral
2.7
8.6
48
168
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.5
8.5
56
212
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.5
8.5
66
1158
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
8.5
199
1192
XF404
NOMESCO Finland
Ambulatory ECG
2.5
8.4
54
202
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
5.2
8.4
18
32
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
9.2
8.4
17
17
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
7.6
8.4
19
23
Q25.0
ICD-10 Finland
Patent ductus arteriosus
3.4
8.4
31
85
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.2
8.4
34
99
WX002
NOMESCO Finland
Sedation and analgesia
2.2
8.3
75
327
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
45.4
8.3
10
*
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
3.7
8.3
27
68
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
3.7
8.3
27
68
E34.31
ICD-10 Finland
Short stature, prenatal disorder
4.4
8.2
21
44
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.2
8.1
33
96
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.3
8.1
31
87
R4190
NOMESCO Finland
Nutritional therapy
1.8
8.0
136
740
ZYC01
NOMESCO Finland
Remote contact by phone
2.2
8.0
69
295
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
4.1
7.9
22
49
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
6.7
7.8
19
26
C09AA02
ATC
enalapril; systemic
3.2
7.8
32
94
N88
ICPC
Epilepsy
4.4
7.8
20
42
IGP01
NOMESCO Finland
Psychiatric family contact
2.1
7.8
78
355
ZXA05
NOMESCO Finland
Left side
2.1
7.7
83
387
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
2.9
7.7
36
114
R2110
NOMESCO Finland
Giving the first information
2.9
7.7
36
114
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
15.6
7.6
12
7
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
7.6
153
875
Z99.1
ICD-10 Finland
Dependence on respirator
10.7
7.6
14
12
C08CA01
ATC
amlodipine; oral
2.7
7.5
42
147
L04AD02
ATC
tacrolimus; systemic
3.3
7.5
29
82
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
2.9
7.5
36
116
H02AB09
ATC
hydrocortisone; systemic
2.3
7.5
59
243
G47.3
ICD-10 Finland
Sleep apnoea
2.6
7.5
44
158
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
9.1
7.5
15
15
WYA30, ,
SPAT
4.6
7.4
18
36
R62
ICD-10 Finland
Lack of expected normal physiological development
40.8
7.3
9
*
Q38.1
ICD-10 Finland
Ankyloglossia
2.8
7.3
36
118
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
7.1
7.3
17
22
EJC20
NOMESCO Finland
Operation on frenulum of tongue
3.3
7.3
28
79
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
3.4
7.3
26
70
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
8.6
7.2
15
16
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.0
7.2
85
411
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
3.9
7.2
21
49
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.9
7.2
34
109
IEP02
NOMESCO Finland
Child-centred family therapy
2.3
7.1
58
242
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
7.1
24
62
RL430, ,
NOMESCO Finland
72.6
7.1
8
*
IEP03
NOMESCO Finland
Focused parental counselling
2.2
7.0
58
244
R4120, ,
SPAT
4.3
7.0
18
38
RS231, ,
NOMESCO Finland
14.3
6.8
11
7
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.9
6.8
93
472
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
5.9
6.8
18
28
KAC00
NOMESCO Finland
Nephrectomy
4.4
6.8
17
35
A08.0
ICD-10 Finland
Rotaviral enteritis
3.4
6.6
24
65
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
5.7
6.6
18
29
A11CC03
ATC
alfacalcidol; systemic
3.0
6.6
29
89
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.0
6.6
29
89
P24
ICPC
Specific learning problem
2.1
6.6
66
300
U04
ICPC
Incontinence urine
3.8
6.6
20
48
M03BX01
ATC
baclofen; systemic
7.2
6.6
15
19
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
3.2
6.5
26
75
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.7
6.5
132
753
XF622
NOMESCO Finland
Measurement of minute volume of heart
6.0
6.5
17
26
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.1
6.5
60
264
61
HP
Catheterization and pressure measurement of the left side of the heart
12.5
6.5
11
8
WZB00, ,
SPAT
0.5
6.5
63
1032
127
Kela drug reimbursment
Transplant complication
2.8
6.4
32
106
RS110, ,
NOMESCO Finland
6.9
6.4
15
20
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.8
6.4
102
544
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
1.8
6.4
93
482
R5110, ,
SPAT
3.9
6.4
19
45
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.9
6.4
19
45
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.3
6.4
24
67
RF420, ,
NOMESCO Finland
7.5
6.3
14
17
OAB43, ,
SPAT
0.6
6.3
87
1283
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
3.6
6.3
21
54
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
2.8
6.2
31
102
XF602
NOMESCO Finland
Bloodpressure monitoring
3.4
6.2
22
59
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.8
6.2
19
46
F80.0
ICD-10 Finland
Specific speech articulation disorder
3.2
6.2
25
73
RT320, ,
NOMESCO Finland
11.1
6.2
11
9
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
11.1
6.2
11
9
RL410, ,
NOMESCO Finland
63.5
6.1
7
*
N99
ICPC
Neurological disease other
9.1
6.1
12
12
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
2.7
6.1
33
114
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
13.0
6.0
10
7
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
418
2426
2.42
26.67
30.0
16.3
1.24
1.23
mmol/l
0.71
410
2340
428
2525
2.41
26.07
24.1
14.9
1.23
1.23
mmol/l
0.99
412
2378
150
584
2.67
22.27
27.1
19.0
1.40
1.37
mmol/l
0.17
143
572
244
1235
2.21
19.92
17.8
12.8
1.37
1.36
mmol/l
0.05
235
1183
33
48
6.43
18.92
1.1
1.0
—
—
—
0
0
250
1344
2.06
16.90
13.2
11.7
5.26
5.17
kpa
0.23
243
1319
255
1395
2.03
16.30
13.4
11.9
5.85
5.77
kpa
0.75
248
1368
252
1390
2.00
15.60
13.5
11.9
1.05
0.94
mmol/l
0.29
214
1122
112
468
2.37
13.89
13.6
7.8
1841.40
1463.54
ng/l
0.20
106
392
83
303
2.66
13.66
38.1
19.1
-0.61
-0.30
mmol/l
0.29
70
259
590
4485
2.39
13.29
29.6
15.4
139.45
139.40
mmol/l
0.27
583
4379
119
521
2.27
13.23
23.5
17.2
106.67
105.45
mmol/l
1.73
119
521
229
1281
1.91
13.15
20.6
9.6
24.02
23.99
mmol/l
0.09
229
1275
242
1379
1.89
13.13
21.1
10.3
0.93
0.72
mmol/l
0.55
190
1010
243
1389
1.89
13.04
21.2
10.5
5.10
5.00
kpa
1.36
238
1353
403
2704
1.83
12.80
8.8
6.5
151.56
131.58
u/l
3.46
386
2576
267
1587
1.84
12.57
13.2
10.1
37.82
38.27
g/l
0.60
259
1520
587
4483
2.30
12.50
29.5
15.3
4.00
3.94
mmol/l
3.56
577
4352
229
1301
1.87
12.41
21.1
10.2
9.48
9.79
kpa
1.80
223
1268
76
283
2.59
12.00
2.0
1.9
24.21
19.83
ng/l
1.05
76
283
206
1158
1.86
11.37
3.6
3.2
2.42
2.41
mmol/l
0.64
197
1078
398
2727
1.75
11.05
18.4
9.7
5.77
6.07
mmol/l
2.57
388
2570
65
234
2.65
10.96
46.5
21.5
95.63
95.73
%
0.04
65
234
64
235
2.59
10.38
10.2
7.1
193.35
229.90
ng/l
0.24
57
214
64
235
2.59
10.38
47.2
21.4
0.68
0.68
%
0.00
64
235
274
1723
1.72
10.08
12.6
9.8
28.00
25.75
umol/l
0.27
255
1597
51
176
2.73
9.34
2.9
4.1
5.41
8.14
index
0.46
37
115
324
2163
1.66
9.29
5.9
4.1
71.70
67.09
nmol/l
2.39
319
2069
196
1159
1.73
8.77
4.7
3.8
—
—
—
0
0
101
488
2.01
8.56
2.9
2.5
5.08
5.37
u/l
0.14
60
281
274
1782
1.64
8.49
7.5
4.9
11.09
32.44
e6/l
3.27
214
1317
148
815
1.80
8.43
5.2
3.6
12.57
13.91
umol/l
1.69
142
792
277
1810
1.63
8.40
7.9
5.2
—
—
—
0
0
52
192
2.55
8.35
3.8
4.5
—
—
—
0
0
49
176
2.61
8.32
2.3
2.2
—
—
—
0
0
143
790
1.79
8.03
6.4
5.8
3.02
1.69
mg/l
0.97
115
559
50
185
2.54
8.00
3.1
4.4
63.69
63.22
g/l
0.13
50
178
138
756
1.80
7.96
5.3
3.6
2.50
2.58
g/l
1.07
131
729
585
4655
1.93
7.95
14.2
10.5
27.67
26.17
u/l
0.66
576
4531
51
192
2.49
7.87
3.4
4.2
556.54
555.02
e6/l
0.01
39
126
92
448
1.97
7.61
3.0
2.5
6.77
6.16
iu/l
0.19
52
275
51
196
2.44
7.55
3.5
4.2
203.31
200.99
e6/l
0.02
39
130
59
244
2.28
7.42
2.6
2.4
—
—
—
0
0
185
1132
1.64
7.07
5.6
3.8
7.02
5.97
e6/l
0.45
172
1017
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
133
2.66
6.81
33.1
25.6
0.33
0.32
iu/ml
0.02
23
88
124
689
1.75
6.75
9.8
8.9
6.41
6.46
umol/l
0.02
104
572
181
1114
1.62
6.71
6.3
4.1
0.67
0.83
e6/l
0.44
106
586
248
1661
1.53
6.33
8.0
4.7
0.19
0.21
e6/l
0.11
188
1188
180
1121
1.60
6.31
6.3
4.2
2.69
1.90
e6/l
0.37
107
597
20
50
3.67
6.22
2.0
1.7
1.18
0.89
iu/ml
0.39
11
28
30
98
2.83
6.13
14.7
10.1
10.78
9.44
mg/l
0.53
30
90
43
170
2.35
6.01
2.2
2.1
—
—
—
0
0
46
189
2.27
5.90
2.5
2.0
—
—
—
0
0
56
257
2.04
5.47
2.9
2.5
—
—
—
0
0
20
55
3.33
5.44
8.5
10.2
—
—
—
0
0
60
283
1.99
5.44
13.9
19.2
0.60
0.60
%
0.02
60
283
50
224
2.08
5.21
13.8
13.3
281.44
520.94
iu/ml
—
9
32
23
71
2.97
5.21
2.5
2.1
18.70
18.75
nmol/l
—
10
20
26
87
2.75
5.11
3.5
5.2
0.35
0.84
index
2.86
26
87
17
44
3.53
5.06
2.2
1.8
0.28
0.23
iu/ml
—
10
29
27
94
2.64
4.94
5.5
5.6
—
—
—
0
0
23
75
2.81
4.75
8.7
8.9
1.97
2.23
mg/l
0.30
18
66
34
136
2.31
4.68
5.4
5.9
2.51
2.20
ug/l
0.30
34
136
16
42
3.48
4.67
2.9
2.3
100.75
97.38
g/l
0.57
16
42
246
1727
1.44
4.65
5.0
4.0
—
—
estimate
—
0
0
15
31
4.41
4.63
2.9
2.7
24.60
17.19
umol/l
0.82
15
31
18
52
3.16
4.56
6.6
5.7
5.07
4.89
kpa
0.37
18
52
95
547
1.65
4.49
3.0
2.3
—
—
—
0
0
115
1468
0.64
4.46
2.6
2.7
—
—
—
0
0
113
681
1.59
4.44
1.5
1.4
20.94
18.88
nmol/l
0.76
103
609
44
201
2.03
4.38
17.5
15.4
399.80
1031.86
u/ml
—
5
29
95
554
1.63
4.27
2.9
2.1
—
—
—
0
0
441
3468
1.40
4.14
15.6
13.0
3.56
3.41
e9/l
0.70
385
2820
468
3723
1.41
4.07
4.5
3.8
14.56
14.51
pmol/l
0.20
442
3418
20
66
2.77
4.07
6.5
8.2
—
—
—
0
0
38
173
2.03
3.84
3.9
4.3
83.08
89.51
ml/min/173m2
0.20
12
47
100
606
1.56
3.83
7.0
3.7
965.85
1321.14
ng/l
0.61
74
333
112
1398
0.66
3.82
2.3
2.5
—
—
—
0
0
34
149
2.10
3.80
2.8
1.7
—
—
—
0
0
48
239
1.86
3.76
1.8
1.4
—
—
—
0
0
48
239
1.86
3.76
1.8
1.4
—
—
—
0
0
42
201
1.93
3.71
17.5
24.0
67.96
70.25
%
0.40
42
201
20
406
0.42
3.67
1.3
1.3
3.02
3.30
ratio
1.18
14
268
13
31
3.81
3.60
14.8
20.0
704.00
747.81
nmol/l
0.12
13
31
602
5072
1.58
3.44
20.9
12.7
23.31
24.18
mg/l
0.29
470
3608
596
5012
1.55
3.41
29.1
18.3
13.40
13.10
%
7.05
590
4955
30
131
2.10
3.41
1.6
1.4
—
—
—
0
0
510
4168
1.39
3.38
5.0
4.3
2.14
1.98
mu/l
2.00
493
3966
189
1332
1.38
3.31
5.3
5.4
7.32
8.82
mmol/l
3.02
181
1266
251
2678
0.75
3.26
2.0
2.1
—
—
—
0
0
106
674
1.49
3.26
3.1
2.3
—
—
—
0
0
12
31
3.52
3.11
1.2
1.5
—
—
—
0
0
8
14
5.17
3.06
2.3
1.4
12.75
9.74
mmol/l
—
8
14
659
5716
2.21
3.06
30.9
19.3
271.10
272.24
e9/l
0.15
641
5450
659
5721
2.18
2.95
30.8
19.1
4.64
4.66
e12/l
0.55
638
5439
59
342
1.60
2.76
1.6
1.4
562.00
21474831.00
pmol/l
0.50
53
312
43
230
1.72
2.73
10.9
11.3
23.37
23.08
mmol/l
0.29
43
221
23
100
2.10
2.68
1.8
1.6
—
—
—
0
0
172
1231
1.34
2.67
2.1
2.0
1.32
1.21
mmol/l
0.87
164
1148
546
5173
0.73
2.64
3.9
4.0
—
—
—
0
0
27
126
1.96
2.62
2.6
2.2
1.13
1.11
g/l
0.03
22
109
66
398
1.54
2.62
1.6
1.9
2.41
2.41
mmol/l
0.12
55
331
47
262
1.65
2.58
2.1
1.8
—
—
—
0
0
153
1083
1.34
2.55
1.8
1.7
98.25
97.05
pmol/l
0.13
80
561
356
2821
1.28
2.55
6.8
4.0
290.45
190.97
e6/l
0.21
11
35
35
180
1.78
2.55
2.7
2.2
69.00
64.79
—
7
14
32
161
1.82
2.50
1.4
1.4
330.40
389.66
ug/g
0.84
22
81
33
168
1.80
2.48
5.2
8.3
179.50
339.35
mg/mmol
0.24
26
159
37
196
1.73
2.45
2.5
2.3
—
—
—
0
0
7
170
0.36
2.32
1.3
1.5
51.92
55.84
ug/l
—
7
170
131
922
1.34
2.26
3.0
3.5
55.55
58.15
u/l
0.32
126
867
27
134
1.84
2.22
6.1
5.6
43.77
17.61
u/ml
0.41
27
134
16
65
2.24
2.22
4.2
2.5
0.73
2.05
ug/l
1.44
16
57
35
190
1.69
2.15
2.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
72
2.15
2.15
1.1
1.3
—
—
—
0
0
27
137
1.80
2.09
1.8
1.7
—
—
—
0
0
23
113
1.85
1.97
1.3
1.3
—
—
—
0
0
47
282
1.53
1.95
1.0
1.0
3.35
3.26
kpa
0.09
40
237
38
217
1.60
1.95
2.7
5.2
221.55
1067.46
e6/l
0.71
31
144
15
63
2.16
1.94
4.3
5.5
20.88
25.61
ug/l
1.04
15
63
289
2285
1.23
1.94
5.4
3.9
0.10
3.22
estimate
0.48
42
382
10
35
2.59
1.92
1.9
1.1
—
—
—
0
0
38
218
1.60
1.91
2.7
5.2
32.39
9.45
e6/l
0.34
31
140
287
2272
1.23
1.89
5.4
3.9
0.00
0.00
estimate
-0.00
43
398
59
375
1.45
1.87
1.0
1.0
8.15
8.85
mu/l
0.41
52
327
19
305
0.55
1.86
1.9
1.8
—
—
—
0
0
22
109
1.84
1.85
2.0
1.5
—
—
—
0
0
8
25
2.89
1.85
2.1
3.6
—
—
—
0
0
47
286
1.51
1.85
1.0
1.0
7.07
7.26
kpa
0.27
40
240
47
286
1.51
1.85
1.0
1.0
-2.91
-2.12
mmol/l
—
9
67
192
1458
1.25
1.84
3.3
3.7
2.61
2.40
mg/l
0.82
176
1323
33
185
1.63
1.83
3.3
3.2
—
—
—
0
0
14
245
0.50
1.81
1.7
1.9
—
—
—
0
0
21
104
1.84
1.78
1.9
1.8
—
—
—
0
0
13
54
2.18
1.74
1.2
1.3
108.77
122.78
pmol/l
0.50
13
54
287
2289
1.22
1.72
5.4
4.0
0.10
0.00
estimate
0.49
42
381
25
133
1.71
1.69
2.7
2.4
2.51
1.93
mmol/l
0.45
17
107
14
61
2.08
1.68
3.0
2.0
29.33
24.03
mg/l
—
9
37
17
80
1.93
1.67
2.9
2.7
1.98
1.68
ug/l
—
10
40
16
74
1.96
1.65
1.1
1.3
—
—
—
0
0
5
12
3.76
1.65
1.2
1.8
1319.68
85.28
mu/l
—
5
12
88
613
1.33
1.65
2.4
2.2
47.84
45.51
ng/l
0.03
46
232
16
259
0.54
1.64
1.4
1.4
—
—
—
0
0
103
737
1.30
1.60
1.7
1.5
213.81
461.79
u/ml
1.00
95
700
334
2717
1.20
1.59
4.8
3.6
34.35
35.76
mmol/mol
2.45
320
2597
7
23
2.75
1.59
1.7
2.2
—
—
—
0
0
357
2926
1.20
1.56
3.2
2.4
5.33
5.38
mmol/l
0.27
342
2683
6
18
3.01
1.56
1.7
1.7
—
—
—
0
0
6
18
3.01
1.56
1.7
1.7
—
—
—
0
0
6
18
3.01
1.56
1.7
1.7
—
—
—
0
0
6
18
3.01
1.56
1.7
1.7
—
—
—
0
0
82
931
0.76
1.52
2.5
2.4
—
—
—
0
0
10
182
0.49
1.48
1.6
1.8
—
—
—
0
0
307
2496
1.19
1.43
6.4
5.3
32.07
27.63
u/l
1.51
300
2411
9
35
2.32
1.43
1.6
1.7
—
—
—
0
0
9
35
2.32
1.43
1.6
1.7
—
—
—
0
0
9
35
2.32
1.43
1.6
1.7
—
—
—
0
0
54
357
1.39
1.42
1.7
1.7
498.57
355.13
mu/l
2.24
49
335
11
47
2.12
1.40
1.8
1.3
—
—
—
0
0
9
36
2.26
1.39
4.1
6.6
194.33
200.28
ug/l
—
9
36
5
15
3.00
1.36
1.0
1.7
—
—
—
0
0
9
37
2.20
1.36
2.7
1.8
—
—
—
0
0
74
837
0.77
1.34
1.9
2.2
—
—
—
0
0
11
48
2.07
1.34
2.4
2.9
1171.64
1106.40
u/ml
0.06
11
48
18
95
1.72
1.29
2.3
1.3
3.83
3.21
u/ml
0.10
12
48
5
16
2.82
1.28
1.0
1.6
—
—
—
0
0
15
75
1.81
1.27
1.6
1.3
—
—
—
0
0
12
193
0.55
1.24
1.6
1.7
—
—
—
0
0
40
259
1.41
1.21
3.5
2.0
—
—
—
0
0
30
184
1.48
1.20
3.5
3.0
—
—
—
0
0
6
23
2.35
1.19
2.8
7.1
0.83
0.48
%
—
6
23
57
656
0.76
1.19
1.3
1.3
2.60
3.33
u/ml
0.21
44
487
52
606
0.75
1.19
1.1
1.2
2.15
1.03
u/ml
0.35
36
448
15
77
1.76
1.18
1.8
1.6
—
—
—
0
0
11
51
1.95
1.16
13.0
9.3
1.22
1.24
mmol/l
0.17
11
45
13
65
1.81
1.12
1.6
2.4
—
—
—
0
0
34
419
0.71
1.12
1.4
1.5
—
—
—
0
0
48
328
1.34
1.08
3.6
2.5
103.52
98.88
au/ml
0.10
27
133
5
19
2.37
1.07
6.2
3.7
4.38
4.70
mmol/l
—
5
19
15
80
1.70
1.06
1.1
1.3
—
—
—
0
0
29
182
1.45
1.06
2.3
1.6
—
—
—
0
0
9
41
1.98
1.04
1.6
1.1
477.00
451.63
mu/l
—
9
41
54
613
0.77
1.04
1.1
1.2
5.03
6.47
u/ml
0.33
42
480
9
42
1.93
1.02
1.6
1.1
68.42
75.40
%
—
9
42
17
95
1.62
1.02
2.1
1.5
523.94
376.68
mu/l
0.91
17
79
15
82
1.66
0.98
1.1
1.1
21.38
34.69
iu/ml
1.22
15
82
53
598
0.78
0.98
1.1
1.2
4.46
3.40
u/ml
0.27
38
457
0
29
0.00
0.96
0.0
1.1
—
4.40
—
0
5
34
226
1.37
0.93
1.3
1.2
—
—
—
0
0
12
63
1.72
0.91
2.7
2.2
—
—
—
0
0
12
63
1.72
0.91
1.2
3.0
3.48
3.08
nmol/l
0.07
12
57
6
26
2.08
0.89
2.2
2.1
—
—
—
0
0
78
830
0.82
0.87
1.1
1.1
—
—
—
0
0
315
2641
1.13
0.85
10.5
7.1
113.64
112.59
ml/min/173m2
0.37
231
1919
36
415
0.77
0.81
1.1
1.1
6.85
7.99
u/ml
0.11
23
295
120
1219
0.86
0.79
3.1
3.7
160.77
89.45
ug/g
0.54
101
1006
39
443
0.78
0.79
1.4
1.5
—
—
—
0
0
16
99
1.46
0.67
1.0
1.1
—
—
—
0
0
30
208
1.31
0.66
1.6
1.5
1295.00
996.08
nmol/l
1.07
24
164
321
2723
1.11
0.66
5.0
3.9
51.32
55.74
ug/l
0.31
312
2611
13
170
0.68
0.65
1.5
1.5
—
—
—
0
0
14
87
1.45
0.58
2.1
1.4
0.54
0.75
ug/l
1.83
14
74
6
32
1.69
0.57
3.0
1.8
—
—
—
0
0
6
33
1.64
0.56
1.5
1.4
—
—
—
0
0
6
33
1.64
0.56
1.5
1.4
—
—
—
0
0
6
33
1.64
0.56
1.5
1.4
—
—
—
0
0
14
88
1.44
0.56
4.0
4.6
—
—
—
0
0
14
88
1.44
0.56
4.0
4.7
—
—
—
0
0
12
73
1.48
0.55
1.0
1.0
—
—
—
0
0
15
183
0.73
0.53
1.5
1.5
0.96
0.91
ratio
—
10
104
15
183
0.73
0.53
1.5
1.5
0.85
1.27
ratio
—
10
104
6
35
1.54
0.53
1.5
1.5
—
—
—
0
0
15
182
0.73
0.52
1.5
1.5
1.45
1.18
ratio
—
10
103
6
36
1.50
0.51
1.5
1.5
—
—
—
0
0
6
36
1.50
0.51
1.5
1.5
—
—
—
0
0
348
2992
1.09
0.50
4.4
3.2
4.18
4.30
mmol/l
1.76
342
2874
20
231
0.77
0.50
1.3
1.4
—
—
—
0
0
274
2335
1.09
0.49
2.2
1.8
1.45
1.51
g/l
0.28
155
1231
10
61
1.48
0.46
1.0
1.1
—
—
—
0
0
10
61
1.48
0.46
1.5
1.5
—
—
—
0
0
41
431
0.84
0.45
1.4
1.3
—
—
—
0
0
7
45
1.40
0.45
1.1
1.2
—
—
nmol/l
—
0
0
13
157
0.74
0.45
1.5
2.1
—
—
—
0
0
116
1133
0.90
0.44
4.0
3.2
1.02
1.02
kg/l
0.77
84
719
37
391
0.84
0.44
1.1
1.1
5.98
11.94
u/ml
1.26
24
264
12
146
0.73
0.43
1.0
1.1
1.42
1.44
g/l
0.12
12
146
8
50
1.44
0.43
1.5
1.1
—
—
—
0
0
47
485
0.86
0.42
3.8
2.5
4483.78
6506.32
u/l
0.28
13
153
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
43
332
1.17
0.41
1.1
1.2
—
22.10
—
0
10
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
260
2440
0.93
0.41
1.7
2.1
1.29
4.05
u/ml
2.75
45
428
11
71
1.40
0.40
1.0
1.0
—
—
—
0
0
12
79
1.37
0.39
1.0
1.0
—
—
—
0
0
5
32
1.40
0.38
1.0
1.1
—
—
—
0
0
31
234
1.20
0.38
2.0
1.5
0.13
0.23
mg/l
1.87
11
96
5
33
1.36
0.37
1.0
1.1
—
—
—
0
0
5
33
1.36
0.37
1.0
1.1
—
—
—
0
0
18
128
1.27
0.37
3.4
3.3
130.11
136.97
g/l
0.71
18
115
16
112
1.29
0.37
1.3
1.4
84.38
75.12
%
0.31
16
112
36
374
0.86
0.36
1.1
1.1
1.77
0.74
u/ml
0.26
15
215
49
495
0.88
0.35
1.2
1.2
16.44
5.39
u/ml
0.31
17
140
6
39
1.38
0.35
1.0
1.1
—
—
—
0
0
45
457
0.87
0.34
1.3
1.2
—
4.80
—
0
20
311
2693
1.07
0.34
4.0
2.9
1.19
1.09
mmol/l
1.56
304
2572
11
74
1.34
0.32
2.2
1.8
—
—
—
0
0
13
148
0.78
0.32
1.2
1.1
0.99
0.82
g/l
2.85
13
148
7
46
1.37
0.31
1.1
1.2
0.66
0.45
nmol/l
—
7
46
21
156
1.21
0.31
1.3
1.1
—
—
—
0
0
16
177
0.81
0.31
1.0
1.1
1.70
8.46
eliau/ml
—
6
53
7
87
0.72
0.31
1.4
1.1
—
—
—
0
0
29
223
1.17
0.31
1.3
1.1
5.35
6.55
iu/ml
—
6
34
7
49
1.28
0.30
1.6
1.7
—
—
—
0
0
8
55
1.31
0.28
1.0
1.1
—
—
—
0
0
20
151
1.19
0.26
1.4
1.1
—
—
—
0
0
10
114
0.78
0.25
1.4
1.4
3.11
13.69
u/ml
—
10
106
12
86
1.26
0.24
12.3
8.8
5.24
4.84
kpa
1.29
12
86
9
69
1.17
0.24
4.2
2.9
10.56
34.76
u/ml
—
9
58
21
219
0.86
0.24
1.4
2.7
1.42
0.43
nmol/l
1.46
21
192
6
76
0.71
0.24
1.0
1.2
1.53
4.34
u/ml
—
6
67
44
434
0.90
0.23
1.4
1.2
—
—
—
0
0
13
95
1.23
0.23
1.7
1.6
—
—
—
0
0
5
35
1.28
0.23
1.0
1.1
—
—
—
0
0
5
35
1.28
0.23
1.0
1.1
—
—
—
0
0
5
35
1.28
0.23
1.0
1.1
—
—
—
0
0
5
35
1.28
0.23
1.0
1.1
—
—
—
0
0
155
1451
0.95
0.23
4.6
3.3
0.00
0.01
estimate
0.80
35
325
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
0
9
0.00
0.21
0.0
1.1
—
1.47
—
0
9
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
27
272
0.89
0.21
1.5
1.3
—
—
—
0
0
6
43
1.25
0.20
1.2
1.2
—
—
—
0
0
11
80
1.24
0.20
1.2
1.3
—
—
—
0
0
14
105
1.20
0.20
1.5
1.6
—
—
—
0
0
334
2933
1.04
0.19
4.2
3.1
1.32
1.38
mmol/l
1.97
325
2798
28
280
0.89
0.19
1.6
1.9
—
—
—
0
0
26
261
0.89
0.19
1.2
1.1
—
1.99
—
0
8
11
81
1.22
0.18
1.2
1.3
—
—
—
0
0
11
81
1.22
0.18
1.2
1.3
—
—
—
0
0
11
81
1.22
0.18
1.2
1.3
—
—
—
0
0
16
123
1.17
0.18
1.2
1.3
—
30.60
—
0
10
13
137
0.85
0.17
1.5
2.1
1.65
4.28
iu/l
—
6
61
16
124
1.16
0.17
1.2
1.3
—
14.46
—
0
5
11
82
1.21
0.16
1.2
1.3
—
—
—
0
0
14
108
1.17
0.15
2.4
1.8
—
—
—
0
0
15
117
1.15
0.15
3.4
2.5
—
—
—
0
0
7
78
0.80
0.14
1.6
1.9
128.86
126.60
%
—
7
78
15
118
1.14
0.13
1.4
1.3
4.35
8.16
u/ml
0.85
15
108
11
84
1.18
0.13
1.2
1.3
—
—
—
0
0
334
2952
1.03
0.12
4.4
3.1
2.54
2.61
mmol/l
0.96
326
2815
119
1034
1.04
0.12
4.9
3.9
0.00
0.00
estimate
-0.00
42
367
114
1055
0.96
0.11
4.2
3.1
0.00
0.00
estimate
0.50
37
317
20
197
0.91
0.11
3.5
1.9
27.36
32.06
%
1.02
14
150
14
111
1.13
0.11
1.1
1.0
1.50
1.40
g/l
0.51
14
106
26
252
0.92
0.11
1.3
1.6
1.98
11.79
u/ml
1.06
19
177
359
3182
1.03
0.10
6.3
4.9
7.27
6.85
mm/h
0.48
349
2985
55
472
1.05
0.09
4.9
4.9
16.26
37.21
mg/mmol
0.33
40
394
95
828
1.03
0.09
1.2
1.3
—
3.00
—
0
5
5
55
0.81
0.08
1.2
1.7
12.80
8.90
umol/l
—
5
55
29
245
1.06
0.08
2.1
1.5
0.20
0.20
g/l
0.04
29
239
29
247
1.06
0.06
2.1
1.6
1.06
1.14
g/l
0.69
29
240
53
460
1.04
0.06
2.7
2.6
24.76
30.71
u/l
1.27
46
362
58
536
0.97
0.06
1.3
1.2
13.79
13.48
iu/ml
0.02
11
99
13
107
1.09
0.05
1.2
1.3
—
1.62
—
0
5
69
633
0.98
0.04
1.8
1.5
1.37
1.39
%
0.12
62
566
10
82
1.10
0.03
14.1
10.8
6.79
5.49
pmol/l
—
10
82
43
395
0.97
0.03
1.8
1.8
—
—
—
0
0
49
448
0.98
0.02
3.2
2.2
160.07
157.15
u/ml
0.03
30
202
53
482
0.99
0.01
1.5
1.4
71.77
131.50
u/ml
0.75
13
138
11
100
0.99
0.00
1.0
1.4
39.00
40.37
u/l
0.10
11
95
11
100
0.99
0.00
3.6
2.2
—
—
—
0
0
11
96
1.03
0.00
1.2
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
10.72
—
0
5
0
5
0.00
0.00
0.0
24.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
273.60
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
4.66
—
0
5
9
85
0.95
-0.00
1.1
1.1
0.32
2.45
u/ml
—
9
85
9
89
0.91
-0.00
3.8
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
17.71
—
0
7
0
6
0.00
-0.00
0.0
4.0
—
—
—
0
0
9
89
0.91
-0.00
1.3
1.2
0.32
1.57
u/ml
—
9
89
7
69
0.91
-0.00
1.6
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
1.19
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_DELAY_MILES_CHILDH – Delayed milestone in childhood
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).